What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Cancer research, Glioma, Stem cell, Cancer stem cell and Cancer.
Jeremy N. Rich combines subjects such as Cancer cell, Brain tumor, Signal transduction and Immunology with his study of Cancer research.
His work carried out in the field of Glioma brings together such families of science as Alkyltransferase, Internal medicine, O6-Benzylguanine and Pathology.
His Stem cell research focuses on Progenitor cell in particular.
The concepts of his Cancer stem cell study are interwoven with issues in Radioresistance and Neurosphere, Adult stem cell.
Jeremy N. Rich has included themes like Cytotoxic T cell and Neuroscience in his Cancer study.
His most cited work include:
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (4594 citations)
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (1184 citations)
- Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor (1048 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Stem cell, Glioma, Cancer stem cell and Cell biology are his primary areas of study.
His Cancer research study integrates concerns from other disciplines, such as Cancer cell, Cancer, Signal transduction and Immunology.
In the field of Stem cell, his study on Neural stem cell overlaps with subjects such as Population.
The study incorporates disciplines such as Internal medicine, Oncology, Phases of clinical research and Pathology in addition to Glioma.
The Internal medicine study combines topics in areas such as Gastroenterology and Surgery.
His work focuses on many connections between Cancer stem cell and other disciplines, such as Brain tumor, that overlap with his field of interest in Neuroscience.
He most often published in these fields:
- Cancer research (69.14%)
- Stem cell (50.78%)
- Glioma (33.20%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (69.14%)
- Stem cell (50.78%)
- Cancer stem cell (37.50%)
In recent papers he was focusing on the following fields of study:
Jeremy N. Rich mainly focuses on Cancer research, Stem cell, Cancer stem cell, Glioma and Chromatin.
His Cancer research research includes elements of Carcinogenesis, Cancer, RNA interference, Ependymoma and Epigenetics.
His Stem cell study necessitates a more in-depth grasp of Cell biology.
As a member of one scientific family, Jeremy N. Rich mostly works in the field of Cancer stem cell, focusing on Tumor initiation and, on occasion, Mutation and Molecular therapy.
His biological study spans a wide range of topics, including Dystroglycan, Cell growth, Platelet, ITGAV and Extracellular matrix.
His Chromatin research is multidisciplinary, incorporating perspectives in Enhancer and Transcription.
Between 2017 and 2021, his most popular works were:
- Challenges to curing primary brain tumours (159 citations)
- Cancer Stem Cells: The Architects of the Tumor Ecosystem. (148 citations)
- Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling (95 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Jeremy N. Rich mostly deals with Cancer research, Stem cell, Cancer stem cell, Epigenetics and Chromatin.
His Cancer research study combines topics from a wide range of disciplines, such as Paracrine signalling, RNA interference, Ependymoma, Regulation of gene expression and Gene silencing.
His Stem cell study combines topics in areas such as Brain tumor, Precursor cell and Glioma.
His research in Cancer stem cell intersects with topics in Neuroscience, Tumor initiation, Dihydroorotate dehydrogenase and Nucleotide.
Jeremy N. Rich combines subjects such as Cell cycle, Histone, microRNA and Glioblastoma with his study of Epigenetics.
His Chromatin study integrates concerns from other disciplines, such as Enhancer, Transcription and Genome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
